Umbilical Cord Stem Cell Secretome Reverses Skin Aging by Boosting Mitophagy

Sunlight leaves its signature on skin over decades: thickened, leathery patches, deepening wrinkles, broken capillaries, and uneven pigment that dermatologists collectively call photoaging. Beyond its cosmetic toll, chronic ultraviolet exposure can progress to precancerous actinic keratosis and even cutaneous malignancies, making it a genuine medical problem rather than a purely aesthetic one. Current remedies all carry drawbacks. Sunscreens depend on diligent reapplication and never block every photon; topical retinoids irritate and peel; antioxidants penetrate poorly and degrade quickly; laser and light-based devices are expensive and can trigger post-inflammatory hyperpigmentation. Now, a study published in Aging Cell offers a strikingly different approach: a cell-free therapeutic derived from human umbilical cord mesenchymal stem cells that appears to reverse key hallmarks of photoaged skin by repairing the cellular machinery that clears damaged mitochondria and, in doing so, silencing a powerful inflammatory pathway implicated in aging throughout the body.

The therapeutic material, known as a secretome, is the complete collection of bioactive molecules that stem cells release into their surroundings, including growth factors, cytokines, nucleic acids such as microRNAs, lipid metabolites, and extracellular vesicles like exosomes. Mounting evidence suggests that the clinical benefits of mesenchymal stem cells come not from the cells themselves engrafting and replacing worn-out tissue, but from these paracrine signals. That insight has fueled interest in secretome-based therapies as safer, more controllable alternatives to live-cell transplantation, eliminating risks of rejection, uncontrolled proliferation, or tumorigenicity. Human umbilical cord-derived mesenchymal stem cells are especially attractive sources because they are readily available, ethically uncontroversial, non-invasive to procure, and expand vigorously in culture. Prior work by the same team showed that this secretome could stimulate hair growth through the PI3K/AKT/mTOR pathway, but its role in photoaging had remained poorly defined.

To test the secretome’s anti-aging potential, researchers at Southern Medical University in Guangzhou, China, built a chronic photoaging model in mice. Over 40 days, depilated dorsal skin was irradiated with a carefully calibrated mixture of UVA and UVB whose intensity ratio of roughly 6.7 to 1 mirrors the spectral balance of natural sunlight reaching Earth’s surface. Doses escalated gradually from 10 to 30 minutes per day, avoiding the acute burns that plague many UV experiments and instead mimicking the cumulative, sub-erythemal sun exposure that ages human skin in real life. The mice developed the expected phenotype: leathery thickening, erythema, scaling, and a measurable collapse in skin elasticity, hydration, and barrier function as water loss through the epidermis climbed. Topical application of the secretome, delivered as 200 microliters daily for 30 days beginning after an adaptation period, visibly and statistically reversed nearly all of it.

Histology told the same story at the tissue level. Hematoxylin and eosin staining revealed that UV-driven epidermal hyperplasia and dermal thickening were substantially attenuated by the treatment. Masson’s trichrome staining showed that chronic irradiation had fragmented and depleted the dermal collagen network, the structural scaffold that keeps skin firm, while secretome-treated skin retained intact collagen fibers and significantly greater total collagen content. Immunohistochemistry and Western blotting traced the molecular basis: UV exposure suppressed the structural collagens COL1 and COL3 while ramping up the matrix-degrading enzymes MMP1, MMP3, and MMP9, and the secretome normalized all of these shifts. Senescence markers responded in parallel. The nuclear envelope protein Lamin B1, which declines as cells age, was restored to near-normal levels, while the cell-cycle inhibitors p16 and p21, elevated by UV stress, were pushed back down.

Notably, the treatment showed a reassuring safety profile. In mice that received the secretome without any UV exposure, modest improvements in hydration and water-loss parameters were observed, indicating support for barrier function under normal conditions, but there was no epidermal or dermal thickening and no alteration of collagen turnover. In other words, the therapy behaves differently depending on context: gentle maintenance when skin is healthy, active repair when skin is damaged. That stress-responsive selectivity matters for any candidate cosmetic or clinical intervention, because it suggests the secretome is not forcing skin into an abnormal proliferative state but rather helping stressed tissue recover its equilibrium.

The mechanistic heart of the study lies in mitochondria, the energy-producing organelles that are both a primary source of reactive oxygen species and particularly vulnerable to UV damage. Chronic irradiation mutates mitochondrial DNA, breaks respiratory chain function, and floods cells with oxidative stress, creating a vicious cycle that drives senescence. Cells normally dispose of dysfunctional mitochondria through mitophagy, a selective autophagy process that tags damaged organelles and delivers them to lysosomes for destruction. The classical PINK1/Parkin pathway orchestrates much of this quality control. Using transmission electron microscopy, the team documented severe mitochondrial injury in UV-exposed skin, including matrix swelling and fragmented cristae, alongside accumulation of mitochondrial proteins TOM20, TIM23, and HSP60 and the autophagy adaptor p62, all signs of clogged disposal machinery. The secretome reversed every one of these defects, restored PINK1 and Parkin levels, and boosted the fusion of mitochondria with lysosomes, confirmed by confocal imaging and colocalization statistics.

Why does clearing broken mitochondria matter so much for aging? The answer lies in a second pathway: cGAS-STING, the innate immune circuit that senses misplaced DNA. When damaged mitochondria leak their DNA into the cytoplasm, the sensor protein cGAS mistakes this self-DNA for a viral invader and synthesizes the messenger cGAMP, which activates STING and triggers a phosphorylation cascade through TBK1, IRF3, and IKK. The result is a flood of type I interferons and inflammatory cytokines, including IL-6, IL-8, and IFN-beta, a chronic low-grade inflammation researchers call inflammaging. The study showed this pathway roaring to life in UV-irradiated mouse skin and UVB-exposed human keratinocytes, with cytosolic double-stranded DNA accumulating visibly under the microscope. Secretome treatment shut the whole cascade down, from cGAS expression through cytokine secretion, both in tissue and in serum.

The causal architecture was tested with an elegant pharmacological epistasis design. The mitophagy inhibitor Mdivi-1, which blocks the fission protein Drp1, abolished the secretome’s protective effect and reactivated cGAS-STING signaling, elevating inflammatory cytokines and restoring senescence markers. Conversely, the mitophagy agonist CCCP mimicked the secretome’s benefits on its own, while the STING inhibitor H151 enhanced protection further. Most tellingly, when Mdivi-1 and H151 were combined, H151 bypassed the mitophagy blockade entirely and restored full protection, demonstrating that STING sits downstream of mitophagy in a strict hierarchy: the secretome protects skin primarily by reactivating mitochondrial housekeeping, which prevents DNA leakage and thereby disarms the inflammatory driver of senescence.

The implications reach well beyond dermatology. The mitophagy-cGAS-STING axis has been implicated in neurodegeneration and cardiac hypertrophy, and this study provides direct in vivo evidence that the same cascade operates in skin aging and can be therapeutically targeted by a cell-free biologic. A standardized secretome, harvested from a single validated donor batch, sterile-filtered, and frozen in aliquots, could sidestep many regulatory and safety hurdles of live-cell therapy while remaining simple to apply topically. The authors caution that murine skin and immortalized keratinocyte lines cannot fully recapitulate human biology, and clinical validation will be essential before any anti-aging product reaches the clinic. Still, the demonstration that boosting a cellular waste-disposal system can quiet an inflammatory aging program offers a compelling mechanistic template, not just for smoother skin, but potentially for a broad class of mitochondrial-driven age-related disorders.

Subject of Research: Cell-free mesenchymal stem cell secretome therapy for skin photoaging via the mitophagy-cGAS-STING axis

Article Title: The Secretome Derived From Human Umbilical Cord Mesenchymal Stem Cells Improves Skin Photoaging by Enhancing Mitophagy to Inhibit the cGAS‐STING Pathway

Article References: Tang, T., Lin, M., Yang, J., Yang, X., Xu, X., Wang, X., Zhang, Y., Chen, Q., Zhao, S., Guo, C., Zhang, H., Zhang, M., Zhang, L., & Wang, X. (2026). The Secretome Derived From Human Umbilical Cord Mesenchymal Stem Cells Improves Skin Photoaging by Enhancing Mitophagy to Inhibit the cGAS ‐ STING Pathway. Aging Cell, 25(9), Article e70701. https://doi.org/10.1111/acel.70701

Image Credits: AI Generated

DOI: 10.1111/acel.70701

Keywords: skin photoaging, mesenchymal stem cells, secretome, mitophagy, cGAS-STING, inflammaging, UV radiation, keratinocytes, cell-free therapy, collagen degradation, senescence, regenerative dermatology